Light Therapy Market Report Scope & Overview:

The Light Therapy Market Size was valued at USD 1.17 Billion in 2025E and is projected to reach USD 1.79 Billion by 2033, growing at a CAGR of 5.50% during the forecast period 2026–2033.

The Light Therapy Market analysis provides an overview of market developments. Rising awareness of sleep and mental health treatments, increased homecare adoption, and growing demand for advanced light therapy devices are driving market growth, supported by technological innovations and expanding consumer accessibility globally.

light therapy device shipments reached 4.2 million units in 2025, driven by increasing awareness of sleep disorders and home-based wellness solutions.

Market Size and Forecast:

  • Market Size in 2025: USD 1.17 Billion

  • Market Size by 2033: USD 1.79 Billion

  • CAGR: 5.50% from 2026 to 2033

  • Base Year: 2025

  • Forecast Period: 2026–2033

  • Historical Data: 2022–2024

Light Therapy Market Trends:

  • Increasing consciousness toward sleep disorders and mental well-being are some of the factors propelling demand for home-based light therapy products.

  • Novel device design, such as portable and wearable devices, is improving accessibility and day-to-day applicability.

  • Light therapy is becoming more accessible and known through online retail and direct-to-consumer channels.

  • The integration of smart technology and app connectivity provides individualized therapy, resulting in enhanced patient engagement and compliance.

  • Growing consumer preference for non-drug, natural health remedies is driving adoption in homecare and clinics.

U.S. Light Therapy Market Insights:

The U.S. Light Therapy Market is projected to grow from USD 0.34 Billion in 2025E to USD 0.49 Billion by 2033, at a CAGR of 4.95%. Growth is driven by growing awareness of sleep and mood disorders, growth in homecare, increasing use of wearable and portable devices, growth in clinical and wellness programs.

Light Therapy Market Growth Drivers:

  • Increasing adoption of non-pharmaceutical wellness solutions for sleep and mood disorders is driving market growth.

Increasing use of non-medical technology solutions for sleep and mood disorders is fueling the Light therapy market growth. The total devices of light therapy such as seasonal affective disorder and improvement sleep reached 2.5 million in 2025 all over the world. In the U.S., Germany and Japan, awareness campaigns are increasing utilisation at home and in the clinic. This is driving demand for portable, wearable and smart devices increasing innovation, enabling access and adoption within consumer and healthcare applications.

Rising preference for non-pharmaceutical sleep and mood therapies drove light therapy device usage to 4.2 million units in 2025, led by blue and red-light devices.

Light Therapy Market Restraints:

  • High device costs and limited insurance coverage are restricting widespread adoption of light therapy treatments globally.

High cost of devices and poor reimbursement are hampering growth of Light Therapy market. In 2025, one-third of interested users obtain clinically validated light therapy systems, hindering widespread deployment for home care and clinical treatment. Meanwhile, smaller clinics and the general public have difficulty accessing it and so it is not yet broadly used. Furthermore, absence of standardized regimens and poor awareness in developing areas impede their use. Despite the increasing prevalence of sleep and mood disorders, these barriers limit widespread.

Light Therapy Market Opportunities:

  • Increasing awareness of sleep and mood disorders creates opportunities for innovative, portable, and home-based light therapy solutions.

Growing prevalence of sleep and mood disorders are acting as a growth opportunity for Light Therapy. 2.8 million New Light Therapy Equipment Users By 2025, the growing home care and clinical applications have elevated light therapy among therapy types. Increasing popularity for smart, wearable and portable gadgets is fuelling growth. With customizable, app-enabled options, manufacturers can quickly address consumer demand with a vast opportunity for new and existing businesses to scale and invest in a lucrative opportunity within an increasingly expanding wellness industry.

Portable, wearable, and home-based light therapy devices accounted for 35% of new device launches in 2025, driven by rising awareness of sleep and mood disorders.

Light Therapy Market Segmentation Analysis:

  • By Product Type, Light Box held the largest market share of 42.67% in 2025, while Wearable Devices are expected to grow at the fastest CAGR of 7.23%.

  • By Light Type, Blue Light dominated with a 38.91% share in 2025, while Red Light is projected to expand at the fastest CAGR of 6.87%.

  • By Application, Seasonal Affective Disorder accounted for the highest market share of 45.12% in 2025, and sleep disorders are projected to record the fastest CAGR of 7.01%.

  • By End User, Homecare segment held the largest share of 48.76% in 2025, while Hospitals & Specialty Centers are expected to grow at the fastest CAGR of 6.95%.

By Product Type, Light Box Dominates While Wearable Devices Expand Rapidly:

Light Box segment dominated the market in 2025, due to clinical acceptance of these devices for seasonal affective disorder and at-home therapy. The decision is consistent with recommended therapies, high effectiveness and the awareness among healthcare professionals. The Wearable Devices segment is the fastest growing in the market with a shipment of 620,000 units in 2025. The growth is attributed to portability, day to day usability and sync with health apps.

By Light Type, Blue Light Dominates While Red Light Expands Rapidly:

Blue Light segment dominated the market, predominantly for seasonal affective disorder and circadian rhythm control. Strong clinical validation and consumer awareness underpin its leadership, with usage of 1.4 million devices. Red Light segment is the fastest growing in the market with 580 thousand devices installed in 2025 on account of rising awareness toward skin health, anti-aging and sleep quality benefits/preferences. Technical advancements and compatibility with portables, wearables further drive the adoption.

By Application, Seasonal Affective Disorder Dominates While Sleep Disorders Expand Rapidly:

Seasonal Affective Disorder segment dominated the market in 2025 due to high prevalence in temperate zones and strong clinical evidence, with more than 1.9 million units used globally. The use of light therapy solutions is being adopted in homecare and clinics. Sleep Disorders segment is the fastest growing in the market with around 750 thousand of such devices used in 2025, spurred by increasing cases of insomnia and circadian rhythm disorders. Growth is propelled by the convenience of at-homecare, app integrations, and increasing interest in non-pharma options.

By End User, Homecare Dominates While Hospitals & Specialty Centers Expand Rapidly:

Homecare segment dominated the market in 2025, partly due to convenience, privacy, and increasing awareness of sleep and mood-disorder treatments, with 2 million individuals adopting light therapy devices at home. The Hospitals & Specialty Centers segment is the fastest growing in the market with 650,000 devices being use in year 2025 as a result of extensive clinical applications expanding uptalk toward mental health program and the greater integrations of non-pharmaceutical therapies into patient’s care.

Light Therapy Market Regional Analysis:

North America Light Therapy Market Insights:

The North America Light Therapy Market dominates globally with a 39.84% share in 2025, driven by high awareness of sleep and mood disorders and established healthcare infrastructure. In 2025, more than 1.7 million devices are consumed in the homecare and clinical environment, such as blue light boxes or wearable solution. The market is being driven by increased home-based therapy adoption, growth of clinical programs, increase in mental wellness services and growing consumer preference for non-pharmaceutical treatments of sleep and mood disorders.

U.S. Light Therapy Market Insights:

The US Light Therapy Market is driven by growing consciousness among people for sleep and mood disorders, adoption of portable and wearable products. Growth continues to be driven by growing home therapy, wellness and clinical strategies. Non-medicinal alternatives are gaining traction with individuals and medical users, increasing market penetration.

Asia-Pacific Light Therapy Market Insights:

Asia-Pacific is the fastest-growing Light Therapy Market with a CAGR of 7.09% during 2026–2033, driven by rising awareness of sleep and mood disorders and expanding wellness adoption. Over 750 thousand devices were used in homecare and clinical applications, with blue light boxes and wearable solutions. Growth is underpinned by growing disposable income, a growing healthcare infrastructure, increasing home-based therapy adoption and government wellness programs in China, Japan & India.

China Light Therapy Market Insights:

The China Light Therapy Market is propelled by increasing awareness about sleep and mood disorders, growing disposable incomes and the prevalence of the urban wellness lifestyle. Homecare is the category leader, though clinics and speciality centres are increasing uptake. The market is also driven by growth in home-based therapy and increased availability through online and retail health channels.

Europe Light Therapy Market Insights:

Europe’s Light Therapy Market is driven by increasing awareness of sleep and mood disorders, expanding wellness programs, and rising disposable incomes. In 2025, over 850,000 light therapy devices were used across the region, with Germany leading, followed by France and Italy. Homecare usage predominated, while clinics and specialty centers saw growing adoption. Growth is further supported by the availability of innovative portable, wearable, and smart devices through retail and healthcare channels.

Germany Light Therapy Market Insights:

Germany Light Therapy Industry is aided by increased awareness regarding sleep and mood disorders, strong well-being culture and growing demand for non-pharmaceutical therapies. Adoption is driven by homecare, and clinics and specialist centres are using these more frequently. Market expansion is facilitated by increasing access via retail, online and health facilities.

Latin America Light Therapy Market Insights:

The Latin American Light Therapy Market is being primarily led by the growing awareness about mood and sleep disorders, robust disposable income, and rising popularity of wellness among urban population. Homecare drives adoption, clinics and specialty centres support use. Furthermore, retail and healthcare distribution channels continue to grow throughout the region.

Middle East and Africa Light Therapy Market Insights:

Middle East & Africa Light Therapy Industry is growing with rising awareness related to sleep and mood disorders, increasing urban wellness trends and establishment of healthcare and retail distribution networks. Homecare drives use, and clinics and specialty centers fuel adoption, driving overall market expansion in the region.

Light Therapy Market Competitive Landscape:

Philips, based in the Netherlands, dominated the light therapy market for SAD and sleep disorders, including its goLITE series, with more than 1.5 million units sold in 2025. Strong Healthcare Portfolio and Brand mean Market Leader Company-License for distribution globally ads value. Through advancement in portable, wearable and clinical devices, partnering with strategic alliances and continuing our commitment to wellness, Philips continues to make light therapy more accessible than ever.

  • In September 2025, Philips unveiled its latest CT and MR innovations at the ASTRO 2025 conference. The new Rembra RT and Areta RT CT platforms aim to drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value.

Beurer, based in Germany, commanded the European light therapy market across homecare and clinical settings, with around 620,000 devices distributed in 2025. Its leadership is driven by easy-to-use, affordable products and a strong retail presence. In addition, emphasis on wellness, quality certifications and consumer education campaigns are supporting adoption. With Beurer’s investment in developing markets and its allying of portable and infrared products, the name stands out as a leading light therapy provider.

  • In December 2024, Beurer introduced the TL35 and TL95 daylight therapy lamps, designed to improve mood, boost energy, and encourage healthy sleep patterns by mimicking the brightness and spectrum of natural sunlight. These lamps aim to support wellness, especially during seasons with reduced sunlight exposure.

Verilux, headquartered in the U.S., is the market leader in North America due to its natural-spectrum light technology, compact design, and user-friendly features, primarily through its HappyLight series for SAD and mood disorders, with over 580,000 devices sold in 2025. Growth is fueled by strong marketing, direct-to-consumer sales and partnerships with wellness programs. As a result of the continual innovation, focus on solutions, and branded offering, Verilux has become one of the leading players in home health lighting.

  • In October 2025, Verilux launched the HappyLight Lumi Plus light therapy lamp, delivering up to 10,000 Lux of UV-free, full-spectrum light. This device is designed to improve sleep, boost mood, increase energy, and enhance focus, providing a natural and effective light therapy solution.

Light Therapy Market Key Players:

Some of the Light Therapy Market Companies are: 

  • Koninklijke Philips N.V.

  • Beurer GmbH

  • Verilux Inc.

  • Northern Light Technologies

  • BioPhotas Inc.

  • PhotoMedex Inc.

  • Lucimed S.A.

  • Revian Inc.

  • Carex Health Brands

  • Lumie

  • Samarit Medical AG

  • TheraLight LLC

  • Johnson & Johnson (Neutrogena)

  • Lumenis

  • Mito Red Light

  • RedDot LED

  • Zepter International

  • Natus Medical

  • Atom Medical

  • Bistos Co.

Light Therapy Market Report Scope:

Report Attributes Details
Market Size in 2025E USD 1.17 Billion 
Market Size by 2033 USD 1.79 Billion 
CAGR CAGR of 5.50% From 2026 to 2033
Base Year 2025E
Forecast Period 2026-2033
Historical Data 2022-2024
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product Type (Light Box, Handheld Devices, Floor & Desk Lamps, Wearable Devices, Others)
• By Light Type (Blue Light, Red Light, White Light, Full Spectrum, Others)
• By Application (Sleep Disorders, Seasonal Affective Disorder, Skin Conditions, Depression, Others)
• By End User (Homecare, Dermatology Clinics, Hospitals & Specialty Centers, Others)
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
Company Profiles Koninklijke Philips N.V., Beurer GmbH, Verilux Inc., Northern Light Technologies, BioPhotas Inc., PhotoMedex Inc., Lucimed S.A., Revian Inc., Carex Health Brands, Lumie, Samarit Medical AG, TheraLight LLC, Johnson & Johnson (Neutrogena), Lumenis, Mito Red Light, RedDot LED, Zepter International, Natus Medical, Atom Medical, Bistos Co.